Loading...
OTCM
CHME
Market cap1mUSD
Oct 06, Last price  
0.05USD
Jan 2017
0.00%
IPO
-98.00%
Name

China Medicine Corp

Chart & performance

D1W1MN
OTCM:CHME chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
68.64%
Rev. gr., 5y
%
Revenues
0
-100.00%
10,400,325023,991,95042,105,38753,647,80664,751,0180
Net income
-7k
L
2,939,660-32,5004,787,8746,875,3699,125,6161,717,677-7,477
CFO
17m
+302.92%
2,546,274-32,500-2,218,208-2,310,1134,209,08416,959,384

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Key people

Senshan Yang
Chief Executive Officer, Director · since 2006
Chi Fung Ho
Chief Financial Officer, Vice President - Finance and Accounting · since 2010
Minhua Liu
Executive Vice President · since 2011
Rachel Gong
Independent Director · since 2006
Independent Director · since 2010
Ryan Shih
Independent Director · since 2010
IPO date
Jun 23, 2005
Employees
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT